A new colon cancer study from Pfizer is revealing that a combination of medications can potentially cut the risk of death in half for people with a specific type of the disease. NBC News medical contributor Dr. Natalie Azar joins TODAY to break down the key takeaways from the trial, potential side effects, and more.
Leave a Reply